ARTICLE | Clinical News
SL-701: Preliminary Ph II STML-701-0114 data
January 6, 2017 9:34 PM UTC
Preliminary data from 42 evaluable patients with relapsed or refractory GBM in stage 1 of the 2-stage, open-label, U.S. Phase II STML-701-0114 trial showed that second-line treatment with subcutaneous...